Common Contracts
4 similar Revenue Interests Purchase Agreement contracts by AxoGen, Inc.
EX-10.6.1 2 d445191dex1061.htm REVENUE INTERESTS PURCHASE AGREEMENT, DATED AS OF OCTOBER 5, 2012 Pursuant to 17 CFR 240.24b-2, confidential information has been omitted in places marked “* * *” and has been filed separately with the Securities and...Revenue Interests Purchase Agreement • May 5th, 2020 • New York
This REVENUE INTERESTS PURCHASE AGREEMENT (as amended, supplemented or otherwise modified from time to time, this “Agreement”) is made and entered into as of October 5, 2012, by and between AxoGen, Inc., a Minnesota corporation (the “Company”), and PDL BioPharma, Inc., a Delaware corporation (“Purchaser”).
EX-10.6.1 2 d532389dex1061.htm REVENUE INTERESTS PURCHASE AGREEMENT Pursuant to 17 CFR 240.24b-2, confidential information has been omitted in places marked “***” and has been filed separately with the Securities and Exchange Commission pursuant to a...Revenue Interests Purchase Agreement • May 5th, 2020 • New York
This REVENUE INTERESTS PURCHASE AGREEMENT (as amended, supplemented or otherwise modified from time to time, this “Agreement”) is made and entered into as of October 5, 2012, by and between AxoGen, Inc., a Minnesota corporation (the “Company”), and PDL BioPharma, Inc., a Delaware corporation (“Purchaser”).
REVENUE INTERESTS PURCHASE AGREEMENT Dated as of October 5, 2012 between AxoGen, Inc. and PDL BioPharma, Inc.Revenue Interests Purchase Agreement • July 30th, 2013 • AxoGen, Inc. • Electromedical & electrotherapeutic apparatus • New York
This REVENUE INTERESTS PURCHASE AGREEMENT (as amended, supplemented or otherwise modified from time to time, this “Agreement”) is made and entered into as of October 5, 2012, by and between AxoGen, Inc., a Minnesota corporation (the “Company”), and PDL BioPharma, Inc., a Delaware corporation (“Purchaser”).
REVENUE INTERESTS PURCHASE AGREEMENT Dated as of October 5, 2012 between AxoGen, Inc. and PDL BioPharma, Inc.Revenue Interests Purchase Agreement • March 12th, 2013 • AxoGen, Inc. • Electromedical & electrotherapeutic apparatus • New York
This REVENUE INTERESTS PURCHASE AGREEMENT (as amended, supplemented or otherwise modified from time to time, this “Agreement”) is made and entered into as of October 5, 2012, by and between AxoGen, Inc., a Minnesota corporation (the “Company”), and PDL BioPharma, Inc., a Delaware corporation (“Purchaser”).
